Real-time enrollment status for this castration-sensitive prostate adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 3:11 AM UTC
| NCT Number | NCT07466498 |
| Recruiting Status | Recruiting |
| Condition | Castration-Sensitive Prostate Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | October 16, 2026 (Yesterday) |
As of October 17, 2026: Clinical trial NCT07466498 is currently recruiting participants. This phase2 study for castration-sensitive prostate adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07466498 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07466498 was last updated Yesterday (October 16, 2026). HelloStudys verifies this status automatically.